Survey of Japanese infants younger than 3 months who were treated with oseltamivir for influenza: Safety of oseltamivir treatment

Scandinavian Journal of Infectious Diseases

Volumn 44, Issue 8, 2012, Pages 605-609

  Morioka, Ichiro ^a   Nonoyama, Shigeaki ^b   Tanaka Taya, Keiko ^c   Ihara, Toshiaki ^d   Sugaya, Norio ^e   Ueta, Ikuya ^f   Kumagai, Takuji ^g   Okada, Kenji ^h   Hosoya, Mitsuaki ⁱ   Okabe, Nobuhiko ^c   Morishima, Tsuneo ^j  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^d MIE NATIONAL HOSPITAL   (Japan)

^e Keiyu Hospital   (Japan)

^f SHIZUOKA CHILDREN'S HOSPITAL   (Japan)

^g Kumagai Pediatric Clinic   (Japan)

^h FUKUOKA NATIONAL HOSPITAL   (Japan)

ⁱ FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^j OKAYAMA UNIVERSITY   (Japan)

more..

Author keywords

Infant; Influenza; Oseltamivir; Outcome; Safety

Indexed keywords

OSELTAMIVIR;

2009 H1N1 INFLUENZA; ANTIVIRAL THERAPY; APNEA; ARTICLE; BODY WEIGHT; BRAIN DISEASE; CLINICAL ARTICLE; CONVALESCENCE; COUGHING; DIARRHEA; DRUG SAFETY; FEEDING BEHAVIOR; FEVER; GROUPS BY AGE; HEALTH SURVEY; HUMAN; INFANT; IRRITABILITY; JAPANESE; LISTLESSNESS; LIVER DYSFUNCTION; MYOCARDITIS; NEWBORN; RHINITIS; SIDE EFFECT; TREATMENT OUTCOME;

ANTIVIRAL AGENTS; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; JAPAN; OSELTAMIVIR; TREATMENT OUTCOME;

EID: 84864055135     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2012.669844     Document Type: Article

References (23)

1. Jhung MA, Swerdlow D, Olsen SJ, Jernigan D, Biggerstaff M, Kamimoto L, et al. Epidemiology of 2009 pandemic influenza A (H1N1) in the United States. Clin Infect Dis 2011;52(Suppl 1):S13-26.
2. Bhat N, Wright JG, Broder KR, Murray EL, Greenberg ME, Glover MJ, et al. Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med 2005;353:2559-67.
3. Cox CM, Blanton L, Dhara R, Brammer L, Finelli L. 2009 Pandemic influenza A (H1N1) deaths among children - United States, 2009-2010. Clin Infect Dis 2011;52(Suppl 1):S69-74.
4. Groothuis JR, Levin MJ, Rabalais GP, Meiklejohn G, Lauer BA. Immunization of high-risk infants younger than 18 months of age with split-product influenza vaccine. Pediatrics 1991;87:823-8.
5. Okamoto S, Kamiya I, Kishida K, Shimakawa T, Fukui T, Morimoto T. Experience with oseltamivir for infants younger than 1 year old in Japan. Pediatr Infect Dis J 2005;24:575-6.
6. Siedler K, Skopnik H. Oseltamivir for treatment of influenza in infants less than one year: a retrospective analysis. Pediatr Infect Dis J 2010;29:495-8.
7. Tamura D, Miura T, Kikuchi Y. Oseltamivir phosphate in infants under 1 year of age with influenza infection. Pediatr Int 2005;47:484.
8. Kimberlin DW, Shalabi M, Abzug MJ, Lang D, Jacobs RF, Storch G, et al. Safety of oseltamivir compared with the adamantanes in children less than 12 months of age. Pediatr Infect Dis J 2010;29:195-8.
9. Pannaraj PS, Tam B, Akan D. Oseltamivir treatment and prophylaxis in a neonatal intensive care unit during a 2009 H1N1 influenza outbreak. J Perinatol 2011;31:487-93.
10. Jernigan DB, Lindstrom SL, Johnson JR, Miller JD, Hoelscher M, Humes R, et al. Detecting 2009 pandemic influenza A (H1N1) virus infection: availability of diagnostic testing led to rapid pandemic response. Clin Infect Dis 2011;52 (Suppl 1):S36-43.
11. World Health Organization. WHO guidelines for pharmacological management of pandemic influenza A(H1N1) 2009 and other influenza viruses. Revised February 2010. Geneva: WHO; 2010.
12. Japan Pediatric Society. A guideline for management of neonates with novel influenza (pandemic A/H1N1 2009) in the early neonatal period. (in Japanese). The Journal of the Japan Pediatric Society 2009;113:1492-4.
13. Japan Pediatric Society. A guideline for management of influenza (including pandemic (H1N1) 2009) in neonates during the early postnatal period in 2010-2011 season] (in Japanese). The Journal of the Japan Pediatric Society 2010;114:2016-8.
14. American Academy of Pediatrics. Policy statement- recommendations for prevention and control of influenza in children, 2010-2011. Pediatrics 2010;126: 816-26.
15. Infectious Disease Surveillance Center. Surveillance report for influenza in Japan, 2007-2011. Japan; 2011. Available at: https://hasseidoko.mhlw.go.jp/ Byogentai/Pdf/data2j.pdf (accessed date: 8 January 2012).
16. Silvennoinen H, Peltola V, Lehtinen P, Vainionpaa R, Heikkinen T. Clinical presentation of influenza in unselected children treated as outpatients. Pediatr Infect Dis J 2009; 28:372-5.
17. Plessa E, Diakakis P, Gardelis J, Thirios A, Koletsi P, Falagas ME. Clinical features, risk factors, and complications among pediatric patients with pandemic influenza A (H1N1). Clin Pediatr (Phila) 2010;49:777-81.
18. Morishima T, Togashi T, Yokota S, Okuno Y, Miyazaki C, Tashiro M, et al. Encephalitis and encephalopathy associated with an influenza epidemic in Japan. Clin Infect Dis 2002:35; 512-7.
19. Ukimura A, Izumi T, Matsumori A. A national survey on myocarditis associated with the 2009 influenza A (H1N1) pandemic in Japan. Circ J 2010;74:2193-9.
20. Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 2008;198:962-70.
21. Aebi T, Weisser M, Bucher E, Hirsch HH, Marsch S, Siegemund M. Co-infection of influenza B and streptococci causing severe pneumonia and septic shock in healthy women. BMC Infect Dis 2010;10:308.
22. Hoffman-La Roche. Letter from the Medical Director, Roche Laboratories Inc. Roche Pharmaceuticals; 2003. Available at: http://www.fda.gov/downloads/ Safety/MedWatch/SafetyInformation/ SafetyAlertsforHumanMedicalProducts/ UCM169493.pdf (accessed date: 8 January 2012).
23. Centers for Disease Control and Prevention. Surveillance for pediatric deaths associated with 2009 pandemic influenza A (H1N1) virus infection - United States, April-August 2009. MMWR Morb Mortal Wkly Rep 2009;58:941-7.